1 Department of Radiation Physics, University of Gothenburg , Göteborg, Sweden .
2 Department of Oncology, Sahlgrenska Academy, University of Gothenburg , Göteborg, Sweden .
Cancer Biother Radiopharm. 2017 Nov;32(9):335-343. doi: 10.1089/cbr.2017.2317. Epub 2017 Nov 10.
In Lu-DOTATATE treatments, bone marrow (BM) is one of the most important organs at risk. The authors previously developed an image-based two-compartment method for BM dosimetry, showing a significant correlation between absorbed dose to BM and hematological toxicity in Lu-DOTATATE treatments. In the present study, they aimed to further evaluate this BM dosimetry method by finding optimal settings for dividing the whole body into two compartments; in terms of minimizing the coefficient of variation (CV) for the individual absorbed doses and studying its correlation to the BM response. The authors have also added specific absorbed fractions for male and female. Finally, they compare this two-compartment method with whole-body dosimetry.
This study included 46 patients with advanced neuroendocrine tumors treated with Lu-DOTATATE on two to five occasions at Sahlgrenska University Hospital. Planar gamma camera images were collected at four time points postinjection, and a segmentation tool using a normalized number of uptake foci (nNUF) to divide the whole body into high- and low-uptake compartments was used. The authors characterized the two-compartment model and compared it with whole-body dosimetry.
The dosimetry method was robust, with an optimal nNUF value of 0.1-0.2. Using an nNUF value of 0.15, the absorbed BM dose was estimated as 0.20 Gy/7.4 GBq, and the CV as 8.4%. Compared to whole-body dosimetry, stronger correlation was found between absorbed dose to BM and hematological response using the two-compartment method. The two-compartment method has potential as a valuable image-based alternative to blood-based BM dosimetry.
在 Lu-DOTATATE 治疗中,骨髓(BM)是最重要的危险器官之一。作者先前开发了一种基于图像的两室方法进行 BM 剂量测定,该方法显示 Lu-DOTATATE 治疗中 BM 吸收剂量与血液毒性之间存在显著相关性。在本研究中,作者旨在通过找到将整个身体分为两个隔室的最佳设置来进一步评估这种 BM 剂量测定方法;具体而言,就是要找到将个体吸收剂量的变异系数(CV)最小化的方法,并研究其与 BM 反应的相关性。作者还添加了男性和女性的特定吸收分数。最后,他们将这种两室方法与全身剂量测定进行了比较。
本研究纳入了在 Sahlgrenska 大学医院接受 Lu-DOTATATE 治疗的 46 例晚期神经内分泌肿瘤患者,他们接受了 2 至 5 次治疗。在注射后四个时间点采集平面伽马相机图像,并使用归一化摄取焦点数量(nNUF)分割工具将整个身体分为高摄取和低摄取隔室。作者对两室模型进行了特征描述,并将其与全身剂量测定进行了比较。
该剂量测定方法具有很强的稳健性,最佳 nNUF 值为 0.1-0.2。使用 nNUF 值为 0.15,估计 BM 吸收剂量为 0.20 Gy/7.4 GBq,CV 为 8.4%。与全身剂量测定相比,两室方法在 BM 吸收剂量与血液学反应之间显示出更强的相关性。两室方法具有作为基于图像的替代血液 BM 剂量测定的潜力。